Your browser doesn't support javascript.
loading
Identification of 13 Novel Loci in a Genome-Wide Association Study on Taiwanese with Hepatocellular Carcinoma.
Liu, Ting-Yuan; Liao, Chi-Chou; Chang, Ya-Sian; Chen, Yu-Chia; Chen, Hong-Da; Lai, I-Lu; Peng, Cheng-Yuan; Chung, Chin-Chun; Chou, Yu-Pao; Tsai, Fuu-Jen; Jeng, Long-Bin; Chang, Jan-Gowth.
Afiliación
  • Liu TY; Center for Precision Medicine and Epigenome Research Center, China Medical University Hospital, Taichung 40447, Taiwan.
  • Liao CC; Million-Person Precision Medicine Initiative, Department of Medical Research, China Medical University Hospital, Taichung 40447, Taiwan.
  • Chang YS; Center for Precision Medicine and Epigenome Research Center, China Medical University Hospital, Taichung 40447, Taiwan.
  • Chen YC; Center for Precision Medicine and Epigenome Research Center, China Medical University Hospital, Taichung 40447, Taiwan.
  • Chen HD; Center for Precision Medicine and Epigenome Research Center, China Medical University Hospital, Taichung 40447, Taiwan.
  • Lai IL; Million-Person Precision Medicine Initiative, Department of Medical Research, China Medical University Hospital, Taichung 40447, Taiwan.
  • Peng CY; Center for Precision Medicine and Epigenome Research Center, China Medical University Hospital, Taichung 40447, Taiwan.
  • Chung CC; Department of Laboratory Medicine, China Medical University Hospital, Taichung 404, Taiwan.
  • Chou YP; Center for Precision Medicine and Epigenome Research Center, China Medical University Hospital, Taichung 40447, Taiwan.
  • Tsai FJ; Department of Internal Medicine, Section of Hepatobiliary Tract, China Medical University Hospital, Taichung 40447, Taiwan.
  • Jeng LB; Center for Precision Medicine and Epigenome Research Center, China Medical University Hospital, Taichung 40447, Taiwan.
  • Chang JG; Center for Precision Medicine and Epigenome Research Center, China Medical University Hospital, Taichung 40447, Taiwan.
Int J Mol Sci ; 24(22)2023 Nov 16.
Article en En | MEDLINE | ID: mdl-38003606
ABSTRACT
Liver cancer is caused by complex interactions among genetic factors, viral infection, alcohol abuse, and metabolic diseases. We conducted a genome-wide association study and polygenic risk score (PRS) model in Taiwan, employing a nonspecific etiology approach, to identify genetic risk factors for hepatocellular carcinoma (HCC). Our analysis of 2836 HCC cases and 134,549 controls revealed 13 novel associated loci such as the FAM66C gene, noncoding genes, liver-fibrosis-related genes, metabolism-related genes, and HCC-related pathway genes. We incorporated the results from the UK Biobank and Japanese database into our study for meta-analysis to validate our findings. We also identified specific subtypes of the major histocompatibility complex that influence both viral infection and HCC progression. Using this data, we developed a PRS to predict HCC risk in the general population, patients with HCC, and HCC-affected families. The PRS demonstrated higher risk scores in families with multiple HCCs and other cancer cases. This study presents a novel approach to HCC risk analysis, identifies seven new genes associated with HCC development, and introduces a reproducible PRS model for risk assessment.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Virosis / Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudio: Systematic_reviews Límite: Humans Idioma: En Revista: Int J Mol Sci Año: 2023 Tipo del documento: Article País de afiliación: Taiwán

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Virosis / Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudio: Systematic_reviews Límite: Humans Idioma: En Revista: Int J Mol Sci Año: 2023 Tipo del documento: Article País de afiliación: Taiwán